GGrantIndex
← Leaderboards

Anna J. Esbensen

Cincinnati Childrens Hosp Med Ctr

$11,515,885
Attributed
$14,367,580
Total exposure
6
Grants
6
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $3.2M · FY200925
$5M$3.8M$2.5M$1.3M$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$14,367,580 · 6

By mechanism

R01$8,089,379 · 2
R33$4,182,561 · 1
R61$1,520,829 · 1
R21$427,050 · 1
R03$147,761 · 1

Top collaborators

Most similar at Cincinnati Childrens Hosp Med Ctr

Same institution · by research overlap

Others in their field

Top investigators on “Intellectual Functioning Disability

Research focus

Intellectual Functioning DisabilityChildExecutive FunctionOutcome MeasureBehavioralMotorClinical TrialsLanguageDown SyndromeBehaviorCognitiveComorbidityAreaParentsPhenotypeAffectEvidence BaseResearch PriorityEfficacy TrialMedicalGenderGeneticReportingSite

Grant awards (24)

Cognitive Outcome Measures in School Age Children with Down Syndrome (ECODS)$916,624
R01 · FY2025 · HD · contact PI
Behavior Measure for Children and Adolescents with Down Syndrome$696,748
R01 · FY2025 · HD · contact PI
Evaluating Assessment and Medication Treatment of ADHD in Children with Down Syndrome$1,080,279
R33 · FY2024 · HD · contact PI
Cognitive Outcome Measures in School Age Children with Down Syndrome (ECODS)$1,000,212
R01 · FY2024 · HD · contact PI
Behavior Measure for Children and Adolescents with Down Syndrome$707,077
R01 · FY2024 · HD · contact PI
Evaluating Assessment and Medication Treatment of ADHD in Children with Down Syndrome$379,219
R33 · FY2024 · HD · contact PI
Evaluating Assessment and Medication Treatment of ADHD in Children with Down Syndrome$1,067,660
R33 · FY2023 · HD · contact PI
Behavior Measure for Children and Adolescents with Down Syndrome$710,495
R01 · FY2023 · HD · contact PI
Evaluating Assessment and Medication Treatment of ADHD in Children with Down Syndrome$549,339
R33 · FY2023 · HD · contact PI
Evaluating Assessment and Medication Treatment of ADHD in Children with Down Syndrome$1,106,064
R33 · FY2022 · HD · contact PI
Behavior Measure for Children and Adolescents with Down Syndrome$687,859
R01 · FY2022 · HD · contact PI
Cognitive Outcome Measures in School Age Children with Down Syndrome$499,849
R01 · FY2022 · HD · contact PI
Cognitive Outcome Measures in School Age Children with Down Syndrome$529,166
R01 · FY2021 · HD · contact PI
Evaluating Assessment and Medication Treatment of ADHD in Children with Down Syndrome$164,639
R61 · FY2021 · HD · contact PI
Cognitive Outcome Measures in School Age Children with Down Syndrome$870,052
R01 · FY2020 · HD · contact PI
Evaluating Assessment and Medication Treatment of ADHD in Children with Down Syndrome$675,867
R61 · FY2020 · HD · contact PI
Evaluating Assessment and Medication Treatment of ADHD in Children with Down Syndrome$680,323
R61 · FY2019 · HD · contact PI
Cognitive Outcome Measures in School Age Children with Down Syndrome$500,402
R01 · FY2019 · HD · contact PI
INCLUDE19 – Evaluating outcome measures in young adults with Down syndrome$406,082
R01 · FY2019 · HD · contact PI
Cognitive Outcome Measures in School Age Children with Down Syndrome$564,813
R01 · FY2018 · HD · contact PI
Treatment of sleep disturbances in school-age children with Down syndrome$193,050
R21 · FY2016 · HD · contact PI
Treatment of sleep disturbances in school-age children with Down syndrome$234,000
R21 · FY2015 · HD · contact PI
Aging in Adults with Down Syndrome$73,511
R03 · FY2010 · HD · contact PI
Aging in Adults with Down Syndrome$74,250
R03 · FY2009 · HD · contact PI